Publication: Switch from Olanzapine Long-Acting Injectable to its Oral Equivalent during COVID-19 Pandemic: a Real World Observational Study
| dc.contributor.author | Miron, Ana-Aliana | |
| dc.contributor.author | Teodorescu, Andreea | |
| dc.contributor.author | Ifteni, Petru | |
| dc.contributor.author | Irimie, Claudia Alexandrina | |
| dc.contributor.author | Dima, Lorena | |
| dc.contributor.author | Petric, Paula-Simina | |
| dc.date.accessioned | 2025-09-25T15:32:00Z | |
| dc.date.issued | 2022-03-02 | |
| dc.description.abstract | ||
| dc.identifier.doi | 10.1007/s11126-021-09924-9 | |
| dc.identifier.issn | 0033-2720 | |
| dc.identifier.issn | 1573-6709 | |
| dc.identifier.uri | https://repository.unitbv.ro/handle/123456789/2192 | |
| dc.publisher | Springer Science and Business Media LLC | |
| dc.relation.ispartof | Psychiatric Quarterly | |
| dc.title | Switch from Olanzapine Long-Acting Injectable to its Oral Equivalent during COVID-19 Pandemic: a Real World Observational Study | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| oaire.citation.issue | 2 | |
| oaire.citation.volume | 93 |
